Skip to main content

Table 4 Characteristics ADTKD-MUC1 and ADTKD-UMOD adults in registry

From: Eight-fold increased COVID-19 mortality in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations: an observational study

Characteristic

ADTKD-MUC1

ADTKD-UMOD

P -value

Odd Ratio (OR) given with 95% Confidence Interval (CI) where applicable

P-value grouping for Kidney Failure Modality

(No Kidney Failure, Dialysis, Kidney Transplant)

To consider a change to the table

n

360

478

  

Gender (% male)

41%

45%

0.19

 

Age, y (mean ± s.d. (median))

47.40 ± 15.8 (47.74)

47.38 ± 14.89 (48.07)

0.97

 

Age > 60 (n,%)

86 (24%)

118 (25%)

0.68

 

Race (% White)

86%

95%

  

Body mass index, kg/m2 (mean ± sd (median))

26.22 ± 5.58 (25.5)

26.86 ± 5.75 (25.8)

0.47

 

Body mass index, greater than 25 kg/m2 (n,%)

161 (55%)

211 (56%)

0.89

 

On dialysis

34 (9%)

26 (5%)

0.0027

0.0011

Living with kidney transplant

166 (46%)

164 (34%)

0.0037

Not on dialysis or kidney transplanted (n, column percent)

159 (44%)

287 (60%)

< 0.0001

Duration kidney failurea < 10 years

104 (29%)

110 (38%)

 

Duration kidney failure 10 to ≤ 15 years

25 (7%)

33 (11%)

 

Duration kidney failure 15 to ≤ 20 years

31 (9%)

18 (6%)

 

Duration kidney failure > 20 years

41 (11%)

25 (9%)

 
  1. aDuration of kidney failure until the start of 2020